Ronglin Wang

748 total citations
28 papers, 539 citations indexed

About

Ronglin Wang is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Ronglin Wang has authored 28 papers receiving a total of 539 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 7 papers in Cancer Research and 5 papers in Oncology. Recurrent topics in Ronglin Wang's work include RNA modifications and cancer (5 papers), Autophagy in Disease and Therapy (4 papers) and Pancreatic and Hepatic Oncology Research (4 papers). Ronglin Wang is often cited by papers focused on RNA modifications and cancer (5 papers), Autophagy in Disease and Therapy (4 papers) and Pancreatic and Hepatic Oncology Research (4 papers). Ronglin Wang collaborates with scholars based in China, United States and United Kingdom. Ronglin Wang's co-authors include Qian Yang, Kai Tao, Haichuan Su, Dayun Feng, Shaosong Yang, Peixiang Ma, Michael P. Murphy, Hong‐Yan Qin, Yajun Shi and Gang Zhao and has published in prestigious journals such as The FASEB Journal, Journal of Neurochemistry and Frontiers in Immunology.

In The Last Decade

Ronglin Wang

26 papers receiving 536 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ronglin Wang China 13 273 120 86 52 51 28 539
Laura Z. Vanags Australia 15 287 1.1× 132 1.1× 61 0.7× 35 0.7× 25 0.5× 20 712
Danfeng Zheng China 14 318 1.2× 145 1.2× 40 0.5× 69 1.3× 32 0.6× 35 539
Yiqin Dai China 14 245 0.9× 55 0.5× 95 1.1× 48 0.9× 28 0.5× 33 702
Yang Huang China 17 458 1.7× 81 0.7× 66 0.8× 45 0.9× 50 1.0× 42 812
Bianca Vezzani Italy 15 417 1.5× 73 0.6× 101 1.2× 37 0.7× 37 0.7× 22 756
Kang Guo China 14 313 1.1× 115 1.0× 66 0.8× 61 1.2× 91 1.8× 30 623
Akram Tayanloo-Beik Iran 15 309 1.1× 85 0.7× 44 0.5× 31 0.6× 31 0.6× 35 633
Cheng Feng China 19 430 1.6× 194 1.6× 70 0.8× 24 0.5× 45 0.9× 48 876
Xiaoyan Lan China 15 285 1.0× 145 1.2× 49 0.6× 32 0.6× 38 0.7× 35 628
Jin Hyuk Jung South Korea 12 368 1.3× 82 0.7× 76 0.9× 29 0.6× 16 0.3× 31 584

Countries citing papers authored by Ronglin Wang

Since Specialization
Citations

This map shows the geographic impact of Ronglin Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ronglin Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ronglin Wang more than expected).

Fields of papers citing papers by Ronglin Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ronglin Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ronglin Wang. The network helps show where Ronglin Wang may publish in the future.

Co-authorship network of co-authors of Ronglin Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Ronglin Wang. A scholar is included among the top collaborators of Ronglin Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ronglin Wang. Ronglin Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Quan, Junqiang Li, Ronglin Wang, et al.. (2025). The type I collagen paradox in PDAC progression: microenvironmental protector turned tumor accomplice. Journal of Translational Medicine. 23(1). 744–744. 2 indexed citations
2.
Wan, Zhuo, Cheng Yang, Ronglin Wang, et al.. (2024). Advances and clinical challenges of mesenchymal stem cell therapy. Frontiers in Immunology. 15. 1421854–1421854. 25 indexed citations
3.
Yang, Cheng‐Ta, et al.. (2024). Pan-cancer analysis of the prognostic and immunological role of hippo-YAP signaling pathway. Discover Oncology. 15(1). 504–504.
4.
Kong, Jingjing, et al.. (2024). Effects of HMGB1/TLR4 on secretion IL-10 and VEGF in human jaw bone-marrow mesenchymal stem cells. Journal of Applied Oral Science. 32. e20230304–e20230304.
5.
Li, Jianbin, et al.. (2023). TIPE2 regulates periodontal inflammation by inhibiting NF-κB p65 phosphorylation. Journal of Applied Oral Science. 31. e20230162–e20230162. 3 indexed citations
6.
Wang, Ronglin, Cheng Yang, Peixiang Ma, et al.. (2023). Machine learning-based integration develops a metabolism-derived consensus model for improving immunotherapy in pancreatic cancer. Journal for ImmunoTherapy of Cancer. 11(9). e007466–e007466. 9 indexed citations
7.
Wang, Ronglin, Peixiang Ma, Yang Song, et al.. (2022). Comprehensive Analysis of 5-Methylcytosine (m5C) Regulators and the Immune Microenvironment in Pancreatic Adenocarcinoma to Aid Immunotherapy. Frontiers in Oncology. 12. 851766–851766. 7 indexed citations
8.
Yang, Cheng, Junqiang Li, Chao Zhang, et al.. (2022). Role of TFRC as a Novel Prognostic Biomarker and in Immunotherapy for Pancreatic Carcinoma. Frontiers in Molecular Biosciences. 9. 756895–756895. 17 indexed citations
9.
Li, Junqiang, Yang Song, Chao Zhang, et al.. (2022). TMEM43 promotes pancreatic cancer progression by stabilizing PRPF3 and regulating RAP2B/ERK axis. Cellular & Molecular Biology Letters. 27(1). 24–24. 16 indexed citations
10.
Zhang, Chao, Junqiang Li, Ronglin Wang, et al.. (2021). Ese-3 Inhibits the Proliferation, Migration, and Invasion of HaCaT Cells by Downregulating PSIP1 and NUCKS1.. 51(4). 470–486. 3 indexed citations
11.
Wang, Ronglin, Junqiang Li, Yang Song, et al.. (2021). Comprehensive Analysis of m6A RNA Methylation Regulators and the Immune Microenvironment to Aid Immunotherapy in Pancreatic Cancer. Frontiers in Immunology. 12. 769425–769425. 24 indexed citations
12.
Zhu, Gang, Ronglin Wang, Jie Lei, et al.. (2021). P53/miR-154 Pathway Regulates the Epithelial-Mesenchymal Transition in Glioblastoma Multiforme Cells by Targeting TCF12. Neuropsychiatric Disease and Treatment. Volume 17. 681–693. 7 indexed citations
13.
Lu, Fangfang, Ronglin Wang, Tiejian Nie, et al.. (2021). Regulation of IFN-Is by MEF2D Promotes Inflammatory Homeostasis in Microglia. Journal of Inflammation Research. Volume 14. 2851–2863. 9 indexed citations
14.
Wang, Ronglin, Fangfang Lu, Gang Zhu, et al.. (2018). Loss of Drosha underlies dopaminergic neuron toxicity in models of Parkinson’s disease. Cell Death and Disease. 9(6). 693–693. 14 indexed citations
15.
Ye, Xi, Dayun Feng, Kai Tao, et al.. (2018). MitoQ protects dopaminergic neurons in a 6-OHDA induced PD model by enhancing Mfn2-dependent mitochondrial fusion via activation of PGC-1α. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1864(9). 2859–2870. 96 indexed citations
16.
Wang, Ronglin, Yuqian Li, Gang Zhu, et al.. (2017). Long noncoding RNA CASC2 predicts the prognosis of glioma patients and functions as a suppressor for gliomas by suppressing Wnt/β-catenin signaling pathway. Neuropsychiatric Disease and Treatment. Volume 13. 1805–1813. 44 indexed citations
17.
Wang, Ronglin, Shaosong Yang, Tiejian Nie, et al.. (2017). Transcription Factors: Potential Cell Death Markers in Parkinson’s Disease. Neuroscience Bulletin. 33(5). 552–560. 14 indexed citations
18.
Nie, Tiejian, Shaosong Yang, Hongwei Ma, et al.. (2016). Regulation of ER stress-induced autophagy by GSK3β-TIP60-ULK1 pathway. Cell Death and Disease. 7(12). e2563–e2563. 68 indexed citations
19.
Bencic, David C., et al.. (2015). Gene Expression Profiling of Zebrafish ( Danio rerio ) Exposed to the Steroidogenesis Inhibitor Ketoconazole. The FASEB Journal. 29(S1). 1 indexed citations
20.
Yang, Jianying, Mengwei Wang, Yuntong Zhu, et al.. (2011). Thermodynamic and kinetic analysis for carbothermal reduction process of CoSb alloy powders used as anode for lithium ion batteries. Journal of Alloys and Compounds. 509(28). 7657–7661. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026